BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23417715)

  • 1. Ampulla of vater adenocarcinoma in a BRCA2 germline mutation carrier.
    Aburjania N; Truskinovsky AM; Overman MJ; Lou E
    J Gastrointest Cancer; 2014 Mar; 45(1):87-90. PubMed ID: 23417715
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenocarcinoma of the ampulla of Vater: does the histopathologic type matter?
    Amptoulach S; Josefsson A; Kavantzas N; Kalaitzakis E
    Scand J Gastroenterol; 2011 Nov; 46(11):1401-3. PubMed ID: 21854095
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenocarcinoma of the ampulla of Vater: what treatment options are available?
    Senatore FJ; Ynson ML; Dasanu CA
    J Oncol Pharm Pract; 2015 Oct; 21(5):364-9. PubMed ID: 24906539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater.
    Kim ST; Lee J; Lee KT; Lee JK; Lee KH; Choi SH; Heo JS; Choi DW; Park SH; Park JO; Lim HY; Park YS; Kang WK
    Med Oncol; 2010 Dec; 27(4):1149-54. PubMed ID: 19898973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better outcome of XELOX chemotherapy in patients with advanced intestinal-type adenocarcinoma of the ampulla of Vater.
    Kim HS; Shin SJ; Kim JH; Kim H; Choi HJ
    Tohoku J Exp Med; 2013 Sep; 231(1):21-8. PubMed ID: 23994910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signet ring cell adenocarcinoma of the ampulla of Vater: a rare pathology.
    Lesquereux-Martínez L; Fernández-Pérez A; Bustamante-Montalvo M
    Rev Esp Enferm Dig; 2012 Sep; 104(9):501-2. PubMed ID: 23130863
    [No Abstract]   [Full Text] [Related]  

  • 7. Early occurrence of chylothorax related to thoracic irradiation and concomitant chemotherapy.
    Chang PY; Chao TY; Dai MS
    Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):291. PubMed ID: 15997925
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.
    Overman MJ; Varadhachary GR; Kopetz S; Adinin R; Lin E; Morris JS; Eng C; Abbruzzese JL; Wolff RA
    J Clin Oncol; 2009 Jun; 27(16):2598-603. PubMed ID: 19164203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival of a patient with neuroendocrine carcinoma of the ampulla of vater with lymph node micrometastasis.
    Watanabe Y; Yamada D; Ogawa Y; Fujino M; Kobayashi K; Ryu S; Tanaka M
    Am Surg; 2013 May; 79(5):E199-201. PubMed ID: 23635569
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic significance of extracapsular lymph node involvement in patients with adenocarcinoma of the ampulla of Vater (Br J Surg 2008; 95: 735-743).
    Sergeant G; Ectors N; Topal B
    Br J Surg; 2008 Sep; 95(9):1188; author reply 1188-9. PubMed ID: 18690628
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of pembrolizumab-induced cutaneous lesions with ruxolitinib.
    Chen CY; Chiu CF; Bai LY
    Eur J Cancer; 2019 May; 113():69-71. PubMed ID: 30986704
    [No Abstract]   [Full Text] [Related]  

  • 12. Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study.
    Gulhati P; Raghav K; Shroff RT; Varadhachary GR; Kopetz S; Javle M; Qiao W; Wang H; Morris J; Wolff RA; Overman MJ
    Cancer; 2017 May; 123(6):1011-1017. PubMed ID: 27859010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of immunohistochemically detectable lymph node metastasis in adenocarcinoma of the ampulla of Vater.
    Mizuno T; Ishizaki Y; Ogura K; Yoshimoto J; Kawasaki S
    Br J Surg; 2006 Feb; 93(2):221-5. PubMed ID: 16363020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Present status and future prospect of the chemotherapy for ampullary cancer].
    Imai H; Ishioka C
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():737-40. PubMed ID: 25857125
    [No Abstract]   [Full Text] [Related]  

  • 15. Collision tumour of the ampulla of Vater: carcinoid and adenocarcinoma.
    Williams IM; Williams NW; Stock D; Foster ME
    HPB Surg; 1997; 10(4):241-4. PubMed ID: 9184878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic adenocarcinoma of parotid gland originating from the ampulla of vater: case report and review of the literature.
    Spyropoulou D; Vassiliou V; Tzelepi V; Kardari M; Tsamandas AC; Kardamakis D
    J Gastrointest Cancer; 2007; 38(2-4):95-8. PubMed ID: 19016351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Images in clinical medicine. Virchow's node (Troisier's sign).
    Loh KY; Yushak AW
    N Engl J Med; 2007 Jul; 357(3):282. PubMed ID: 17634463
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic significance of extracapsular lymph node involvement in patients with adenocarcinoma of the ampulla of Vater.
    van der Gaag NA; ten Kate FJ; Lagarde SM; Busch OR; van Gulik TM; Gouma DJ
    Br J Surg; 2008 Jun; 95(6):735-43. PubMed ID: 18300268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte nuclear factor (HNF) 4α expression distinguishes ampullary cancer subtypes and prognosis after resection.
    Ehehalt F; Rümmele P; Kersting S; Lang-Schwarz C; Rückert F; Hartmann A; Dietmaier W; Terracciano L; Aust DE; Jahnke B; Saeger HD; Pilarsky C; Grützmann R
    Ann Surg; 2011 Aug; 254(2):302-10. PubMed ID: 21494118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
    Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
    J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.